MAOB and serum lipopolysaccharide activity: Both in vitro and in vivo, MAO-B inhibition by the clinical grade drug rasagiline prevents IL-1β secretion, and MAO-B deficient mice display an impaired response to LPS-mediated endotoxemia (68).